WP2 - Translational adrenal cancer models
Objectives
- Identification and characterization of agents with antiproliferative properties for ACC treatment
- Screening and preclinical testing of antiangiogenic therapies for MPH
- Utilization of personalized adrenal cancer tumour models to predict treatment response
WP Leader
Prof. Felix Beuschlein, 
Ludwig-Maximilians-University Munich
WP Partners
Centre National de la Recherche Scientifique
Institut National de la Santé et de la Recherche Médicale
